Biohaven Pharmaceutical Holding Operating Income 2016-2022 | BHVN
Biohaven Pharmaceutical Holding annual/quarterly operating income history and growth rate from 2016 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Biohaven Pharmaceutical Holding operating income for the quarter ending March 31, 2022 was $-0.054B, a 77.16% decline year-over-year.
- Biohaven Pharmaceutical Holding operating income for the twelve months ending March 31, 2022 was $-0.522B, a 28.48% decline year-over-year.
- Biohaven Pharmaceutical Holding annual operating income for 2021 was $-0.704B, a 9.09% increase from 2020.
- Biohaven Pharmaceutical Holding annual operating income for 2020 was $-0.645B, a 34.7% increase from 2019.
- Biohaven Pharmaceutical Holding annual operating income for 2019 was $-0.479B, a 113.37% increase from 2018.
Biohaven Pharmaceutical Holding Annual Operating Income
(Millions of US $) |
| 2021 |
$-704 |
| 2020 |
$-645 |
| 2019 |
$-479 |
| 2018 |
$-225 |
| 2017 |
$-108 |
| 2016 |
$-61 |
| 2015 |
$-10 |
Biohaven Pharmaceutical Holding Quarterly Operating Income
(Millions of US $) |
| 2022-03-31 |
$-54 |
| 2021-12-31 |
$-157 |
| 2021-09-30 |
$-140 |
| 2021-06-30 |
$-172 |
| 2021-03-31 |
$-236 |
| 2020-12-31 |
$-171 |
| 2020-09-30 |
$-163 |
| 2020-06-30 |
$-161 |
| 2020-03-31 |
$-151 |
| 2019-12-31 |
$-135 |
| 2019-09-30 |
$-90 |
| 2019-06-30 |
$-199 |
| 2019-03-31 |
$-54 |
| 2018-12-31 |
$-48 |
| 2018-09-30 |
$-55 |
| 2018-06-30 |
$-38 |
| 2018-03-31 |
$-83 |
| 2017-12-31 |
$-28 |
| 2017-09-30 |
$-40 |
| 2017-06-30 |
$-25 |
| 2017-03-31 |
$-14 |
| 2016-12-31 |
$-23 |
| 2016-09-30 |
$-28 |
| 2016-06-30 |
$-7 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.057B |
$0.463B |
|
Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.
|
